Evidence map›Paper›PMID 37159457›Full record

ArticlePLoS biology2023

Atlas of the anatomical localization of atypical chemokine receptors in healthy mice.

Serena Melgrati, Egle Radice, Rafet Ameti, Elin Hub, Sylvia Thelen, Pawel Pelczar, David Jarrossay, Antal Rot, Marcus Thelen

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. GPR182 is a lipoprotein receptor for dietary fat absorption.The Journal of clinical investigation · 2026
    Article
  2. Review
  3. Review
  4. Circulating and Urinary CCL20 in Human Kidney Disease.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Atypical chemokine receptors in the immune system.Nature reviews. Immunology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Serena MelgratiInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Egle RadiceInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Rafet AmetiInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Elin HubCentre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, London, United Kingdom.
Sylvia ThelenInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Pawel PelczarUniversity of Basel, Center for Transgenic Models, Basel, Switzerland.
David JarrossayInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Antal RotCentre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, London, United Kingdom.
Marcus ThelenInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Università della Svizzera italiana · CHQueen Mary University of London · GBUniversity of Basel · CHUniversity of Bern · CHWilliam Harvey Research Institute · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Atypical chemokine receptors (ACKRs) scavenge chemokines and can contribute to gradient formation by binding, internalizing, and delivering chemokines for lysosomal degradation. ACKRs do not couple to G-proteins and fail to induce typical signaling induced by chemokine receptors. ACKR3, which binds and scavenges CXCL12 and CXCL11, is known to be expressed in vascular endothelium, where it has immediate access to circulating chemokines. ACKR4, which binds and scavenges CCL19, CCL20, CCL21, CCL22, and CCL25, has also been detected in lymphatic and blood vessels of secondary lymphoid organs, where it clears chemokines to facilitate cell migration. Recently, GPR182, a novel ACKR-like scavenger receptor, has been identified and partially deorphanized. Multiple studies point towards the potential coexpression of these 3 ACKRs, which all interact with homeostatic chemokines, in defined cellular microenvironments of several organs. However, an extensive map of ACKR3, ACKR4, and GPR182 expression in mice has been missing. In order to reliably detect ACKR expression and coexpression, in the absence of specific anti-ACKR antibodies, we generated fluorescent reporter mice, ACKR3GFP/+, ACKR4GFP/+, GPR182mCherry/+, and engineered fluorescently labeled ACKR-selective chimeric chemokines for in vivo uptake. Our study on young healthy mice revealed unique and common expression patterns of ACKRs in primary and secondary lymphoid organs, small intestine, colon, liver, and kidney. Furthermore, using chimeric chemokines, we were able to detect distinct zonal expression and activity of ACKR4 and GPR182 in the liver, which suggests their cooperative relationship. This study provides a broad comparative view and a solid stepping stone for future functional explorations of ACKRs based on the microanatomical localization and distinct and cooperative roles of these powerful chemokine scavengers.

Indexed as

Signal TransductionAnimalsCell MovementChemokine CCL19MiceChemokine CCL19

Identifiers

PMID37159457
PMCPMC10198502
OpenAlexW4376121166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.